Vimarsana
Biggest News Aggregation in the World

Page 14 - Molecular Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Testing Today - Breaking & Trending Today

Biomarker Testing in Gastrointestinal and Lung Cancers - Vimarsana News

Biomarker Testing in Gastrointestinal and Lung Cancers

Comprehensive insights on biomarker testing practices for patients with lung or gastrointestinal cancers.

Molecular Testing in Breast Cancer - Vimarsana News

Molecular Testing in Breast Cancer

A breast medical oncologist and nurse practitioner review molecular testing practices for patients with breast cancer.

Repeated Molecular Testing Indicates Dynamic Disease Profile in Patients With PV, ET - Vimarsana News

Repeated Molecular Testing Indicates Dynamic Disease Profile in Patients With PV, ET

Patients with polycythemia vera (PV) and essential thrombocythemia (ET) require repeated molecular testing and improved prognostic tools.

Source: ajmc.com
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2-mutant Advanced Lung Cancer in DESTINY-Lung02 Phase II Trial - Vimarsana News

ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2-mutant Advanced Lung Cancer in DESTINY-Lung02 Phase II Trial

AstraZeneca and Daiichi Sankyo’s ENHERTU showed objective response rates of 49% and 56% with 5.4mg/kg and 6.4mg/kg doses respectively in primary analysis ENHERTU provided a median...

Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS ... - Vimarsana News

Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS ...

Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS ...